Financial News

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Tempest Therapeutics, Inc. - Common Stock (NQ: TPST )

0.9301 -0.0021 (-0.23%)
Streaming Delayed Price Updated: 4:00 PM EST, Feb 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Tempest Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 Next >
Why Is OpGen (OPGN) Stock Up 540% Today?
OpGen stock is undergoing a massive rally on Thursday following as OPGN investors react to two pieces of news from the company! 
Via InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
Pre-market stock movers are a hot topic among traders on Thursday and we're offering all of the latest coverage this morning! 
Via InvestorPlace
Tempest Therapeutics, Microsoft, Birkenstock, Novo Nordisk, Tesla: Why These 5 Stocks Are On Investors' Radars Today
Major U.S. stock indices ended in the green on Wednesday, with the Nasdaq Composite marking notable gains of nearly 100 points. 
Via Benzinga
Topics Stocks
Exposures US Equities
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
TPST Stock: 7 Things to Know About Tempest Therapeutics
Are you curious about the recent surge from Tempest Therapeutics? Here's a closer look at this company and at TPST stock. 
Via InvestorPlace
Crude Oil Down 2.5%; Silk Road Medical Shares Plummet
U.S. stocks traded mostly higher toward the end of trading, with the Nasdaq Composite gaining around 50 points on Wednesday. The Dow traded down 0.01% to 33,736.15 while the NASDAQ rose 0.42% to... 
Via Benzinga
Topics Stocks
Exposures Fossil Fuels US Equities
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
Wall Street Warms Up to Tempest as TPST Stock Surges 1,500%
TPST stock is surging higher after the company released new positive data concerning its TPST-1120 drug candidate. 
Via InvestorPlace
Dow Turns Lower; Tempest Therapeutics Shares Spike Higher
U.S. stocks traded mixed midway through trading, with the Dow Jones falling more than 50 points on Wednesday. The Dow traded down 0.19% to 33,674.66 while the NASDAQ rose 0.18% to 13,586.67. The S&P... 
Via Benzinga
Topics Stocks
Exposures US Equities
Why Astra Space Shares Are Trading Lower By 22%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Gainers Tempest Therapeutics, Inc. (NASDAQ: TPST) shares jumped 1067% to $2.80 after the company released new data demonstrating superiority of TPST-1120 arm across multiple study endpoints in... 
Via Benzinga
Dow Surges Over 100 Points; US Producer Prices Rise In September
U.S. stocks traded higher this morning, with the Dow Jones gaining more than 100 points on Wednesday. Following the market opening Wednesday, the Dow traded up 0.39% to 33,869.26 while the NASDAQ rose... 
Via Benzinga
Topics Stocks
Exposures US Equities
Google AI-Powered Chatbot's Ethical Concerns, MGM Hackers Waited For Days Before Issuing Financial Demands, Costco Accused Of Sharing Confidential Health Data With Facebook: Today's Top Stories
Bloomberg Google's AI Dilemma - Bard's Promise Versus Ethical Concerns 
Via Benzinga
Topics Artificial Intelligence Hacking
Exposures Artificial Intelligence Information Security
800% In One Session - Why Is Cancer Focused Tempest Therapeutics Stock Soaring Today
Tempest Therapeutics Inc (NASDAQ: TPST) released new and updated results from the planned data analysis of an ongoing Phase 1b/2 study of TPST-1120 in the first-line treatment of patients with... 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Why VOXX International Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket
Gainers 
Via Benzinga
Why Is Hyliion (HYLN) Stock Down 37% Today?
Hyliion stock is falling on Wednesday as investors in HYLN react to news of the company considering strategic alternatives. 
Via InvestorPlace
Why Is Silk Road Medical (SILK) Stock Down 40% Today?
Silk Road Medical stock is falling hard on Wednesday as SILK investors react to the company's preliminary earnings results for Q3 2023. 
Via InvestorPlace
Tempest Adopts Limited Duration Stockholder Rights Plan
From Tempest Therapeutics
Via GlobeNewswire
Tempest Releases New Data Demonstrating Superiority of TPST-1120 Arm Across Multiple Study Endpoints in Randomized First-Line HCC Study
From Tempest Therapeutics
Via GlobeNewswire
Why Is Wheeler Real Estate IT (WHLR) Stock Up 116% Today?
Wheeler Real Estate IT stock is taking off on Wednesday with heavy trading of WHLR shares despite a lack of news from the REIT company. 
Via InvestorPlace
Why Is Tempest Therapeutics (TPST) Stock Up 325% Today?
Tempest Therapeutics stock is rocketing higher on Wednesday as TPST investors await news from the company concerning a clinical trial. 
Via InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
Pre-market stock movers are a hot topic on Wednesday morning and we're covering all of the latest news investors need to know about! 
Via InvestorPlace
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
Tempest to Report New and Updated Data from Global Randomized Combination Study of TPST-1120 in First-Line Hepatocellular Carcinoma
Webcasted Conference Call on Wednesday, October 11, 2023 at 8:30 a.m. ET 
From Tempest Therapeutics
Via GlobeNewswire
Stocks That Hit 52-Week Lows On Tuesday
  Tuesday saw 132 companies set new 52-week lows. 
Via Benzinga
Why Immunic Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket
Gainers SuperCom Ltd. (NASDAQ: SPCB) shares rose 78.4% to $0.6425 in pre-market trading, after falling 13% on Monday. 
Via Benzinga
Navigating the Roller Coaster of Recent Penny Stock Surges
Recent surges in penny stocks, like Secoo (SECO), Tempest Therapeutics (TPST), and OpGen (OPGN), have fueled speculation and excitement in penny stocks. 
Via MarketBeat
Tempest Announces Expanded Role for Sam Whiting, M.D., Ph.D., as Chief Medical Officer and Head of Research and Development
From Tempest Therapeutics
Via GlobeNewswire
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
Stocks That Hit 52-Week Lows On Tuesday
  On Tuesday, 386 stocks made new 52-week lows. 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Use the myMotherLode.com Keyword Search to go straight to a specific page

Popular Pages

  • Local News
  • US News
  • Weather
  • State News
  • Events
  • Traffic
  • Sports
  • Dining Guide
  • Real Estate
  • Classifieds
  • Financial News
  • Fire Info
Terms of Service Privacy Policy
© Copyright 2000-2019 Clarke Broadcasting Corporation. All rights reserved.
Feedback